Discontinued — last reported Q4 '17
Zoetis Finite Lived Intangible Assets - Gross increased by 0.3% to $2.60B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.0%, from $2.53B to $2.60B. Over 5 years (FY 2020 to FY 2025), Finite Lived Intangible Assets - Gross shows relatively stable performance with a -2.0% CAGR.
An increase typically signals recent strategic acquisitions or significant investment in intellectual property, while a decrease reflects asset retirement or impairment.
This is the total historical cost of intangible assets with a defined useful life, such as patents, trademarks, and acqu...
Large healthcare companies frequently carry significant gross intangible assets due to the high volume of M&A activity in the sector.
finite_lived_intangible_assets_gross| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.91B | $2.89B | $2.83B | $2.85B | $2.84B | $2.62B | $2.65B | $2.62B | $2.66B | $2.72B | $2.64B | $2.64B | $2.57B | $2.58B | $2.54B | $2.53B | $2.58B | $2.59B | $2.60B | $2.60B |
| QoQ Change | — | -1.0% | -1.8% | +0.7% | -0.6% | -7.7% | +1.3% | -1.1% | +1.4% | +2.3% | -2.9% | +0.0% | -2.6% | +0.3% | -1.6% | -0.4% | +2.1% | +0.5% | +0.2% | +0.3% |
| YoY Change | — | — | — | — | -2.6% | -9.3% | -6.4% | -8.1% | -6.3% | +3.9% | -0.4% | +0.6% | -3.3% | -5.2% | -3.9% | -4.3% | +0.3% | +0.5% | +2.3% | +3.0% |